References
- Eschenhagen T , ForceT, EwerMSet al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology Eur. J. Heart Fail. 13 ( 1 ), 1 – 10 ( 2011 ).
- Parashar S . Building bridges: the emerging field of cardio-oncology . Future Cardiol.11 ( 4 ), 377 – 382 ( 2015 ).
- Jahangir E , PolinNM, LavieCJ, FazioS . The link between lipids, statins, and cancer: is there a role for cardio-oncology?Future Cardiol.11 ( 4 ), 389 – 393 ( 2015 ).
- Codón JC , Rosillo RodríguezSO, López FernándezT . Cardiotoxicity from the cardiologist’s perspective . Future Cardiol.11 ( 4 ), 425 – 432 ( 2015 ).
- Storozynsky E . Multimodality assessment and treatment of chemotherapy induced cardiotoxicityFuture Cardiol.11 ( 4 ), 421 – 424 ( 2015 ).
- Piper S . Heart failure and chemotherapeutic agents: a review . Future Cardiol.11 ( 4 ), 453 – 470 ( 2015 ).
- Fradley MG , Pinilla-IbarzJ . Arrhythmic complications of tyrosine kinase inhibitorsFuture Cardiol.11 ( 4 ), 395 – 399 ( 2015 ).
- Salvatorelli E , MennaP, MinottiG . Managing anthracycline-induced cardiotoxicity: beginning with the end in mind . Future Cardiol.11 ( 4 ), 363 – 366 ( 2015 ).
- Beukema JC , LangendijkJA, MuijsCT . Cardiac toxicity in the radiation treatment of oesophageal cancer: an emerging concern . Future Cardiol.11 ( 4 ), 367 – 369 ( 2015 ).
- Barac A . Improving prediction of cardiovascular complications of cancer therapy: what does the future hold?Future Cardiol.11 ( 4 ), 383 – 387 ( 2015 ).
- Khouri MG , KleinMR, VelazquezEJ, JonesLW . Current and emerging modalities for detection of cardiotoxicity in cardio-oncologyFuture Cardiol.11 ( 4 ), 471 – 484 ( 2015 ).
- Collier P , KoneruS, TamarappooB, GriffinB . Cardio-oncology: strain imaging to detect cancer therapeutics-related cardiac dysfunction – are we there yet?Future Cardiol.11 ( 4 ), 401 – 405 ( 2015 ).
- Yu AF , JonesLW . Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training . Future Cardiol.11 ( 4 ), 441 – 452 ( 2015 ).
- Berkman AM , LakoskiSG . The potential of aerobic exercise training in mitigating cardiovascular side effects of cancer therapy . Future Cardiol.11 ( 4 ), 407 – 411 ( 2015 ).
- Mulrooney DA , DuprezD . Caring for cancer survivors – more than just checking the blood pressure and measuring the ejection fraction . Future Cardiol.11 ( 4 ), 371 – 375 ( 2015 ).
- Montoro N , López-SendónJL . Heart failure years after cancer treatment . Future Cardiol.11 ( 4 ), 433 – 440 ( 2015 ).
- Okwuosa TM , AkhterN, WilliamsKA, DeCaraJM . Building a cardio-oncology program in a small to medium-sized, non-primary cancer center, academic hospital in the United States: challenges and pitfalls . Future Cardiol.11 ( 4 ), 413 – 420 ( 2015 ).
- Lestuzzi C , De PaoliA, BaresicT, MioloG, BuonadonnaA . Malignant cardiac tumors; diagnosis and treatment . Future Cardiol.11 ( 4 ), 485 – 500 ( 2015 ).